Sunny Deol’s Suryaa Faces Controversy as Doctors Object to Film’s Teaser and CBFC Clarifies Certification Status

Sunny Deol’s upcoming Hindi film Suryaa: Ant Se Aarambh Tak has drawn criticism from medical professionals ahead of its scheduled theatrical release. The Indian Medical Association (IMA) raised concerns about the film’s promotional material, arguing that its portrayal of corruption in healthcare and violence against doctors could affect public trust in the medical profession.

The controversy emerged in October 2026, before the film had been submitted to the Central Board of Film Certification (CBFC). The certification board’s status clarification is an important distinction: the reported objections concern the teaser and promotional content, while the CBFC had not yet formally assessed the film for certification, according to media reports.

Why Has the IMA Objected to Suryaa?

The IMA’s concern centres on what it describes as a generalisation of corruption across the healthcare system. The association argued that promotional scenes could leave audiences with the impression that unethical practices are widespread among doctors, rather than the actions of particular individuals.

The medical body has also raised concerns about scenes that appear to depict physical attacks on doctors, nursing staff and other hospital workers. It said that presenting such violence as justified or heroic could risk normalising aggression against healthcare professionals.

The association has emphasised that it does not defend corruption or professional misconduct. Its position, as reported by Indian news outlets, is that individual cases of wrongdoing should be investigated and addressed through appropriate legal and disciplinary procedures without damaging the reputation or safety of the wider medical community.

These are the IMA’s objections to the promotional material; they should not be treated as a final assessment of the complete film. The full movie had not been submitted for certification at the time of the reported clarification.

What Action Has the Indian Medical Association Requested?

According to reports published on October 22 and 23, 2026, the IMA wrote to Union Information and Broadcasting Minister Ashwini Vaishnaw to raise its concerns about the film’s portrayal of the medical profession.

The association sought an impartial review of the film’s content and asked the authorities to consider whether corrective steps were needed. It also called for appropriate action, including a possible ban, if such action were justified under the applicable law.

The request reflects the distinction between creative expression and the concerns raised by a professional association about how a real-world occupation is represented. The IMA argues that fictional portrayals can have consequences when they appear to generalise misconduct or present violence against healthcare workers as acceptable.

However, a request for review or a possible ban is not itself a ban, and the reports do not establish that the authorities had issued such an order. The association’s position should therefore be described as a demand for scrutiny and possible action, rather than a final legal outcome.

What Has the CBFC Said About the Film?

The Central Board of Film Certification had not received Suryaa: Ant Se Aarambh Tak for certification when the controversy was reported. The clarification was attributed in media coverage to the Ministry of Information and Broadcasting.

This means the board had not yet completed a certification review of the film at that stage. It would therefore be inaccurate to say that the CBFC had approved, rejected or ordered changes to the movie based on the reported controversy.

The distinction matters because public objections to a teaser can arise before a film enters the formal certification process. Any later decision would need to be reported separately and supported by a new, reliable update.

For audiences following the story, the key confirmed development in the October reports was that the IMA had raised concerns while the film remained outside the CBFC’s certification process.

What Is Suryaa: Ant Se Aarambh Tak About?

Suryaa: Ant Se Aarambh Tak is a Hindi crime thriller starring Sunny Deol. Reports about its promotional material describe a story involving personal tragedy and a man who begins questioning the medical system after being drawn into a disturbing chain of events.

The teaser, released on October 19 according to contemporary coverage, presents a conflict involving alleged wrongdoing in healthcare. That premise and the way the promotional scenes frame the conflict are central to the IMA’s objections.

The criticism should not be confused with proof that the film depicts every doctor negatively or that its complete narrative has been reviewed by the authorities. The available reports describe the association’s interpretation of the promotional material, not an independent finding about the finished film.

Cast and Release Date

Alongside Sunny Deol, the reported cast includes Ravi Kishan, Pragya Jaiswal, Tanushree Chakraborty, Manish Wadhwa, Tinu Anand, Virti Vaghani and Jisshu Sengupta. Other names reported in coverage include Khalid Siddiqui, Anoop Trivedi and Rohit Tiwari.

The film was scheduled for a theatrical release on November 20, 2026, according to reports published during the controversy. That is the reported release date, not a guarantee that the schedule cannot change. Readers should check for an official announcement if a later update affects the release plan.

Why the Controversy Matters

The dispute highlights a recurring question in popular cinema: how should films portray wrongdoing within professions that play a vital role in society? Medical malpractice and corruption can be legitimate subjects for a crime thriller, but the IMA argues that the promotional material risks presenting individual misconduct as representative of the wider profession.

The opposing consideration is that a teaser offers only a brief view of a film, not necessarily the full context of its story or characters. An assessment of the complete movie would require more than assumptions based solely on promotional clips.

For now, the most accurate way to understand the dispute is to separate the reported facts from the competing positions. The IMA objected to the promotional portrayal and sought review; the CBFC had not yet received the film for certification. The reports do not establish a final certification decision or a confirmed ban.

Frequently Asked Questions

Why has the IMA objected to Sunny Deol’s Suryaa?

The IMA raised concerns that the promotional material generalises corruption in healthcare and depicts violence against doctors and other healthcare workers in ways that could undermine public trust or normalise attacks.

Has the CBFC banned Suryaa: Ant Se Aarambh Tak?

The cited October 2026 reports do not establish that the film was banned. They state that it had not yet been submitted to the CBFC for certification at the time of the clarification.

What action does the IMA want?

The association has sought an impartial review, corrective measures where appropriate, and consideration of a ban or other action if justified under the law.

Who stars in Suryaa: Ant Se Aarambh Tak?

The reported cast includes Sunny Deol, Ravi Kishan, Pragya Jaiswal, Tanushree Chakraborty, Manish Wadhwa, Tinu Anand, Virti Vaghani and Jisshu Sengupta, among others.

When is Suryaa scheduled to release?

Media reports published during the controversy listed November 20, 2026, as the planned theatrical release date. Check for a later official update before relying on that schedule.

Conclusion

Sunny Deol’s Suryaa: Ant Se Aarambh Tak has faced objections from the Indian Medical Association over how its teaser appears to portray healthcare corruption and violence against medical professionals. The association requested a review and possible corrective action, while the CBFC clarification reported in October stated that the film had not yet been submitted for certification.

The controversy remains distinct from a formal certification decision. Any further development—whether a response from the filmmakers, an official review or a change to the release schedule—should be reported on the basis of new, reliable information.